Home > Insider Trading > Filing (0001209191-20-046484)

Filing Details

Accession Number:: 0001209191-20-046484
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-12 20:01:26
Reporting Period:: 2020-08-10

Accepted Time:: 2020-08-12 20:01:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1510487	Principia Biopharma Inc.	PRNB	Pharmaceutical Preparations (2834)	263487603

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1751719	M David Goldstein	C/O Principia Biopharma Inc. 220 E. Grand Avenue South San Francisco CA 94080	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-08-10	2,447	$3.00	34,186	No	4	M	Direct
Common Stock	Acquisiton	2020-08-10	3,553	$3.18	37,739	No	4	M	Direct
Common Stock	Disposition	2020-08-10	858	$86.11	36,881	No	4	S	Direct
Common Stock	Disposition	2020-08-10	700	$86.92	36,181	No	4	S	Direct
Common Stock	Disposition	2020-08-10	2,534	$88.40	33,647	No	4	S	Direct
Common Stock	Disposition	2020-08-10	700	$89.68	32,947	No	4	S	Direct
Common Stock	Disposition	2020-08-10	1,108	$90.99	31,839	No	4	S	Direct
Common Stock	Disposition	2020-08-10	100	$93.34	31,739	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2020-08-10	2,447	$0.00	2,447	$3.00
Common Stock	Employee Stock Option (right to buy)	Disposition	2020-08-10	3,553	$0.00	3,553	$3.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2023-10-23	No	4	M	Direct
12,960		2024-06-26	No	4	M	Direct

Footnotes

Includes 771 shares acquired under the Employment Stock Purchase Plan on May 15, 2020.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Represents the weighted average sales price per share. The shares sold at prices ranging from $85.79 to $86.41 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Represents the weighted average sales price per share. The shares sold at prices ranging from $88.12 to $88.78 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Represents the weighted average sales price per share. The shares sold at prices ranging from $89.55 to $89.74 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Represents the weighted average sales price per share. The shares sold at prices ranging from $90.85 to $91.49 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The stock option is fully vested and immediately exercisable.